Go to journal home page - Drug Discovery Today

Drug Discovery Today

Volume 24, Issue 3

Pages 665-930 (March 2019)

Actions for selected articles

/

Contents

    1. Contents page 1

      Page i
      View PDF
    1. Contents page 2

      Page ii
      View PDF
    1. Contents page 3

      Page iii
      View PDF
  1. Editorial

    1. Behavior, experience, skill, and training (BEST): a four-pillar framework for career development in science

      Pages 665-667
  2. Perspective

    1. Feature

      1. An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer — against all odds?

        Pages 668-672
        View PDF
      2. When more isn’t merrier: pharmaceutical alliance networks and breakthrough innovation

        Pages 673-677
        View PDF
      3. Acceleration of rare disease therapeutic development: a case study of AGIL-AADC

        Pages 678-684
  3. REVIEWS

    1. Foundation

      1. Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents

        Pages 685-702
    2. Keynote

      1. TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension

        Pages 703-716
      2. Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products

        Pages 717-725
      3. Repurposing host-based therapeutics to control coronavirus and influenza virus

        Pages 726-736
        View PDF
      4. Paving the way for successful islet encapsulation

        Pages 737-748
      5. Functionalized nanographene oxide in biomedicine applications: bioinspired surface modifications, multidrug shielding, and site-specific trafficking

        Pages 749-762
    3. Gene to Screen

      1. Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?

        Pages 763-772
    4. Informatics

      1. Artificial intelligence in drug development: present status and future prospects

        Pages 773-780
      2. Computational modeling for formulation design

        Pages 781-788
    5. Post Screen

      1. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions

        Pages 789-795
      2. Pharmaceutical cocrystals: from serendipity to design to application

        Pages 796-804
      3. Efficient drug discovery by rational lead hybridization based on crystallographic overlay

        Pages 805-813
      4. Post-translational modification of ESKAPE pathogens as a potential target in drug discovery

        Pages 814-822
      5. Hurdles in gene therapy regulatory approval: a retrospective analysis of European Marketing Authorization Applications

        Pages 823-828
        View PDF
      6. The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development

        Pages 829-834
      7. Ultrasmall iron oxide nanoparticles: synthesis, surface modification, assembly, and biomedical applications

        Pages 835-844
      8. Gastric-acid-mediated drug–drug interactions with direct-acting antiviral medications for hepatitis C virus infection: clinical relevance and mitigation strategies

        Pages 845-857
      9. Solid nanoparticles for oral antimicrobial drug delivery: a review

        Pages 858-866
      10. Orphan drugs: major development challenges at the clinical stage

        Pages 867-872
      11. Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases

        Pages 873-882
      12. A unified mapping framework of multifaceted pharmacodynamic responses to hypertension interventions

        Pages 883-889
      13. Adverse drug reactions on sexual functioning: a systematic overview

        Pages 890-897
      14. Fullerene-based delivery systems

        Pages 898-905
      15. Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor

        Pages 906-915
      16. Phosphinic acids: current status and potential for drug discovery

        Pages 916-929

ISSN: 1359-6446